Selected research
Industry Research
Biomedical CRO Industry Research Report 2026
Market perspective
The global Biomedical CRO market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Biomedical CRO market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Biomedical CRO market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Biomedical CRO market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Biomedical CRO include Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, PPD, ICON Plc, Pharmaron, Inotiv and ChemPartner, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Biomedical CRO market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biomedical CRO.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biomedical CRO Market by Company
Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD
ICON Plc
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology
Biomedical CRO Segment by Type
Preclinical CRO
Clinical CRO
Biomedical CRO Segment by Application
Biological Industry
Medical Industry
Biomedical CRO Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomedical CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical CRO.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biomedical CRO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Preclinical CRO
- Clinical CRO
Applications
- Biological Industry
- Medical Industry
Companies covered
- Charles River
- Wuxi AppTec
- Labcorp
- Eurofins Scientific
- PPD
- ICON Plc
- Pharmaron
- Inotiv
- ChemPartner
- JOINN Lab
- EVOTEC
- Medicilon
- Crown Bioscience
- Champion Oncology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biomedical CRO by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Preclinical CRO
- 2.2.3 Clinical CRO
- 2.3 Biomedical CRO by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biological Industry
- 2.3.3 Medical Industry
- 2.4 Assumptions and Limitations
3 Biomedical CRO Breakdown Data by Type
- 3.1 Global Biomedical CRO Historic Market Size by Type (2021-2026)
- 3.2 Global Biomedical CRO Forecasted Market Size by Type (2027-2032)
4 Biomedical CRO Breakdown Data by Application
- 4.1 Global Biomedical CRO Historic Market Size by Application (2021-2026)
- 4.2 Global Biomedical CRO Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biomedical CRO Market Perspective (2021-2032)
- 5.2 Global Biomedical CRO Growth Trends by Region
- 5.2.1 Global Biomedical CRO Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biomedical CRO Historic Market Size by Region (2021-2026)
- 5.2.3 Biomedical CRO Forecasted Market Size by Region (2027-2032)
- 5.3 Biomedical CRO Market Dynamics
- 5.3.1 Biomedical CRO Industry Trends
- 5.3.2 Biomedical CRO Market Drivers
- 5.3.3 Biomedical CRO Market Challenges
- 5.3.4 Biomedical CRO Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biomedical CRO Players by Revenue
- 6.1.1 Global Top Biomedical CRO Players by Revenue (2021-2026)
- 6.1.2 Global Biomedical CRO Revenue Market Share by Players (2021-2026)
- 6.2 Global Biomedical CRO Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biomedical CRO Head Office and Area Served
- 6.4 Global Biomedical CRO Players, Product Type & Application
- 6.5 Global Biomedical CRO Manufacturers Established Date
- 6.6 Global Biomedical CRO Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biomedical CRO Market Size (2021-2032)
- 7.2 North America Biomedical CRO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biomedical CRO Market Size by Country (2021-2026)
- 7.4 North America Biomedical CRO Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biomedical CRO Market Size (2021-2032)
- 8.2 Europe Biomedical CRO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biomedical CRO Market Size by Country (2021-2026)
- 8.4 Europe Biomedical CRO Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biomedical CRO Market Size (2021-2032)
- 9.2 Asia-Pacific Biomedical CRO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biomedical CRO Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biomedical CRO Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biomedical CRO Market Size (2021-2032)
- 10.2 South America Biomedical CRO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biomedical CRO Market Size by Country (2021-2026)
- 10.4 South America Biomedical CRO Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biomedical CRO Market Size (2021-2032)
- 11.2 Middle East & Africa Biomedical CRO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biomedical CRO Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biomedical CRO Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Charles River
- 12.1.1 Charles River Company Information
- 12.1.2 Charles River Business Overview
- 12.1.3 Charles River Revenue in Biomedical CRO Business (2021-2026)
- 12.1.4 Charles River Biomedical CRO Product Portfolio
- 12.1.5 Charles River Recent Developments
- 12.2 Wuxi AppTec
- 12.2.1 Wuxi AppTec Company Information
- 12.2.2 Wuxi AppTec Business Overview
- 12.2.3 Wuxi AppTec Revenue in Biomedical CRO Business (2021-2026)
- 12.2.4 Wuxi AppTec Biomedical CRO Product Portfolio
- 12.2.5 Wuxi AppTec Recent Developments
- 12.3 Labcorp
- 12.3.1 Labcorp Company Information
- 12.3.2 Labcorp Business Overview
- 12.3.3 Labcorp Revenue in Biomedical CRO Business (2021-2026)
- 12.3.4 Labcorp Biomedical CRO Product Portfolio
- 12.3.5 Labcorp Recent Developments
- 12.4 Eurofins Scientific
- 12.4.1 Eurofins Scientific Company Information
- 12.4.2 Eurofins Scientific Business Overview
- 12.4.3 Eurofins Scientific Revenue in Biomedical CRO Business (2021-2026)
- 12.4.4 Eurofins Scientific Biomedical CRO Product Portfolio
- 12.4.5 Eurofins Scientific Recent Developments
- 12.5 PPD
- 12.5.1 PPD Company Information
- 12.5.2 PPD Business Overview
- 12.5.3 PPD Revenue in Biomedical CRO Business (2021-2026)
- 12.5.4 PPD Biomedical CRO Product Portfolio
- 12.5.5 PPD Recent Developments
- 12.6 ICON Plc
- 12.6.1 ICON Plc Company Information
- 12.6.2 ICON Plc Business Overview
- 12.6.3 ICON Plc Revenue in Biomedical CRO Business (2021-2026)
- 12.6.4 ICON Plc Biomedical CRO Product Portfolio
- 12.6.5 ICON Plc Recent Developments
- 12.7 Pharmaron
- 12.7.1 Pharmaron Company Information
- 12.7.2 Pharmaron Business Overview
- 12.7.3 Pharmaron Revenue in Biomedical CRO Business (2021-2026)
- 12.7.4 Pharmaron Biomedical CRO Product Portfolio
- 12.7.5 Pharmaron Recent Developments
- 12.8 Inotiv
- 12.8.1 Inotiv Company Information
- 12.8.2 Inotiv Business Overview
- 12.8.3 Inotiv Revenue in Biomedical CRO Business (2021-2026)
- 12.8.4 Inotiv Biomedical CRO Product Portfolio
- 12.8.5 Inotiv Recent Developments
- 12.9 ChemPartner
- 12.9.1 ChemPartner Company Information
- 12.9.2 ChemPartner Business Overview
- 12.9.3 ChemPartner Revenue in Biomedical CRO Business (2021-2026)
- 12.9.4 ChemPartner Biomedical CRO Product Portfolio
- 12.9.5 ChemPartner Recent Developments
- 12.10 JOINN Lab
- 12.10.1 JOINN Lab Company Information
- 12.10.2 JOINN Lab Business Overview
- 12.10.3 JOINN Lab Revenue in Biomedical CRO Business (2021-2026)
- 12.10.4 JOINN Lab Biomedical CRO Product Portfolio
- 12.10.5 JOINN Lab Recent Developments
- 12.11 EVOTEC
- 12.11.1 EVOTEC Company Information
- 12.11.2 EVOTEC Business Overview
- 12.11.3 EVOTEC Revenue in Biomedical CRO Business (2021-2026)
- 12.11.4 EVOTEC Biomedical CRO Product Portfolio
- 12.11.5 EVOTEC Recent Developments
- 12.12 Medicilon
- 12.12.1 Medicilon Company Information
- 12.12.2 Medicilon Business Overview
- 12.12.3 Medicilon Revenue in Biomedical CRO Business (2021-2026)
- 12.12.4 Medicilon Biomedical CRO Product Portfolio
- 12.12.5 Medicilon Recent Developments
- 12.13 Crown Bioscience
- 12.13.1 Crown Bioscience Company Information
- 12.13.2 Crown Bioscience Business Overview
- 12.13.3 Crown Bioscience Revenue in Biomedical CRO Business (2021-2026)
- 12.13.4 Crown Bioscience Biomedical CRO Product Portfolio
- 12.13.5 Crown Bioscience Recent Developments
- 12.14 Champion Oncology
- 12.14.1 Champion Oncology Company Information
- 12.14.2 Champion Oncology Business Overview
- 12.14.3 Champion Oncology Revenue in Biomedical CRO Business (2021-2026)
- 12.14.4 Champion Oncology Biomedical CRO Product Portfolio
- 12.14.5 Champion Oncology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst